Acceleron Pharma Inc.
Methods of increasing sarcolemmal utrophin

Last updated:

Abstract:

In certain aspects, the present invention provides compositions and methods for inducing utrophin expression in muscle with an ActRIIB protein as therapy for muscular dystrophy. The present invention also provides methods of screening compounds that modulate activity of an ActRIIB protein and/or an ActRIIB ligand.

Status:
Grant
Type:

Utility

Filling date:

15 Mar 2017

Issue date:

6 Apr 2021